Integra LifeSciences Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Integra LifeSciences Holdings's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $1,541,573,000. Profit margin reached 4%. Total operating expenses were $836,391,000.

Profit Margin

Integra LifeSciences Holdings Corporation (NASDAQ:IART): Profit margin
2014 928.30M 34.00M 3.66%
2015 882.73M -3.51M -0.4%
2016 992.07M 74.56M 7.52%
2017 1.18B 64.74M 5.45%
2018 1.47B 60.80M 4.13%
2019 1.51B 50.20M 3.31%
2020 1.37B 133.89M 9.76%
2021 1.54B 169.07M 10.96%
2022 1.55B 180.55M 11.59%
2023 1.54B 67.74M 4.39%

IART Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
1.54B1.55B1.54B1.37B1.51B1.47B1.18B992.07M882.73M928.30M
Cost of revenue
653.18M587.35M597.80M520.83M564.68M571.49M435.51M349.08M326.54M352.80M
Gross profit
888.39M970.31M944.64M851.03M952.87M900.94M752.72M642.98M556.19M575.50M
Operating exp.
Research and development
174.59M101.19M93.05M77.38M79.57M78.04M63.45M58.15M50.89M51.59M
Selling and marketing
0000000000
Total operating expenses
836.39M731.39M747.41M699.66M794.2M789.94M707.92M527.64M476.60M509.96M
Operating income
111.52M238.92M197.23M151.37M178.97M110.99M44.80M115.34M79.58M65.54M
Other income (expenses), net
-30.45M-25.02M17.44M-57.85M-118.87M8.28M-33.41M845K-18.91M-24.87M
Income before tax
81.06M213.89M214.67M93.52M60.10M57.40M11.38M90.40M60.67M42.97M
Income tax expense
13.32M33.34M45.60M-40.37M9.90M-3.39M-53.35M15.84M53.82M8.97M
Net income
67.74M180.55M169.07M133.89M50.20M60.80M64.74M74.56M-3.51M34.00M
Earnings per share
Basic EPS
0.872.1821.580.590.730.831-0.040.52
Diluted EPS
0.842.161.981.570.580.720.820.94-0.040.52
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source